Although these protective effects were seen with the syngeneic mouse melanoma tumor, B16F10L, apoA-I therapy was also shown to be effective against human melanoma (A375) in nude mice (Zamanian-Daryoush et al., 2013). Here, APOA1 is linked to neoplasm.